Advanced materials and processing for drug delivery: The past and the future

Advanced Drug Delivery Reviews

Volumn 65, Issue 1, 2013, Pages 104-120

  Zhang, Ying ^a   Chan, Hon Fai ^a   Leong, Kam W ^a  

^a Duke University   (United States)

Author keywords

Combinatorial chemistry; Commercialized drug delivery system; Microfluidics; Nanoparticle; Natural polymers; Particle replication in non wetting template; Polymer drug conjugate; Polyplex; Step flash imprint lithography

Indexed keywords

COMBINATORIAL CHEMISTRY; DRUG DELIVERY SYSTEM; IMPRINT LITHOGRAPHY; NON-WETTING; POLYMER-DRUG CONJUGATE; POLYPLEXES;

BIOASSAY; BIOCHIPS; BIOLOGICAL MATERIALS; HEALTH CARE; MICROFLUIDICS; NANOPARTICLES; NANOTECHNOLOGY; NATURAL POLYMERS;

DRUG DELIVERY;

CAMPTOTHECIN; CARMUSTINE; CYCLOSPORIN A; DOXORUBICIN; DRUG CARRIER; MICROSPHERE; NANOPARTICLE; PACLITAXEL POLIGLUMEX; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT PROTEIN; TEMOZOLOMIDE;

BIOCOMPATIBILITY; BIODEGRADATION; CHEMORADIOTHERAPY; COMBINATORIAL CHEMISTRY; CONTROLLED DRUG RELEASE; DRUG APPROVAL; DRUG DELIVERY SYSTEM; EMULSION; EVAPORATION; GLIOBLASTOMA; HUMAN; MICROFLUIDICS; NANOFABRICATION; NANOTECHNOLOGY; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; REVIEW;

BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 84873244450     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.10.003     Document Type: Review

References (205)

1. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
2. Verma R.K.G. Sanjay current status of drug delivery technologies and future directions. Pharm. Technol. On-Line 2001, 25:4.
3. Almeida A.J., Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Deliv. Rev. 2007, 59:478-490.
4. Zhang L., Pornpattananangku D., Hu C.M., Huang C.M. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 2010, 17:585-594.
5. Schipper M.L., Iyer G., Koh A.L., Cheng Z., Ebenstein Y., Aharoni A., Keren S., Bentolila L.A., Li J., Rao J., Chen X., Banin U., Wu A.M., Sinclair R., Weiss S., Gambhir S.S. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5:126-134.
6. Carrstensen H., Muller R.H., Muller B.W. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. Clin. Nutr. 1992, 11:289-297.
7. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., Terada Y., Kano M.R., Miyazono K., Uesaka M., Nishiyama N., Kataoka K. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 2011, 6:815-823.
8. Sajja H.K., East M.P., Mao H., Wang Y.A., Nie S., Yang L. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr. Drug Discov. Technol. 2009, 6:43-51.
9. Jain R., Shah N.H., Malick A.W., Rhodes C.T. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev. Ind. Pharm. 1998, 24:703-727.
10. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
11. Yoo H.S., Lee K.H., Oh J.E., Park T.G. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J. Control. Release 2000, 68:419-431.
12. Avgoustakis K., Beletsi A., Panagi Z., Klepetsanis P., Karydas A.G., Ithakissios D.S. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 2002, 79:123-135.
13. Fontana G., Licciardi M., Mansueto S., Schillaci D., Giammona G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 2001, 22:2857-2865.
14. Suh H., Jeong B., Rathi R., Kim S.W. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. J. Biomed. Mater. Res. 1998, 42:331-338.
15. Carino G.P., Jacob J.S., Mathiowitz E. Nanosphere based oral insulin delivery. J. Control. Release 2000, 65:261-269.
16. Panyam J., Dali M.M., Sahoo S.K., Ma W., Chakravarthi S.S., Amidon G.L., Levy R.J., Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D, L-lactide-co-glycolide) nano- and microparticles. J. Control. Release 2003, 92:173-187.
17. van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 2000, 17:1159-1167.
18. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002, 16:1217-1226.
19. Prabha S., Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm. Res. 2004, 21:354-364.
20. Elamanchili P., Lutsiak C.M., Hamdy S., Diwan M., Samuel J. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. J. Immunother. 2007, 30:378-395.
21. Lu J.M., Wang X., Marin-Muller C., Wang H., Lin P.H., Yao Q., Chen C. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert. Rev. Mol. Diagn. 2009, 9:325-341.
22. Faisant N., Siepmann J., Benoit J.P. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur. J. Pharm. Sci. 2002, 15:355-366.
23. Crotts G., Park T.G. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J. Microencapsul. 1998, 15:699-713.
24. Kranz H., Ubrich N., Maincent P., Bodmeier R. Physicomechanical properties of biodegradable poly(D, L-lactide) and poly(D, L-lactide-co-glycolide) films in the dry and wet states. J. Pharm. Sci. 2000, 89:1558-1566.
25. Shirahama H., Ichimaru A., Tsutsumi C., Nakayama Y., Yasuda H. Characteristics of the biodegradability and physical properties of stereocomplexes between poly(L-lactide) and poly(D-lactide) copolymers. J. Polymer Sci., Part A: Polymer Chem. 2005, 43:438-454.
26. Tsuji H. Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and applications. Macromol. Biosci. 2005, 5:569-597.
27. Tan J.P., Kim S.H., Nederberg F., Appel E.A., Waymouth R.M., Zhang Y., Hedrick J.L., Yang Y.Y. Hierarchical supermolecular structures for sustained drug release. Small 2009, 5:1504-1507.
28. Lawson H.C., Sampath P., Bohan E., Park M.C., Hussain N., Olivi A., Weingart J., Kleinberg L., Brem H. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J. Neurooncol. 2007, 83:61-70.
29. Bock H.C., Puchner M.J., Lohmann F., Schutze M., Koll S., Ketter R., Buchalla R., Rainov N., Kantelhardt S.R., Rohde V., Giese A. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Neurosurg. Rev. 2010, 33:441-449.
30. Zhao Z., Wang J., Mao H.Q., Leong K.W. Polyphosphoesters in drug and gene delivery. Adv. Drug Deliv. Rev. 2003, 55:483-499.
31. Wang Y.C., Yuan Y.Y., Du J.Z., Yang X.Z., Wang J. Recent progress in polyphosphoesters: from controlled synthesis to biomedical applications. Macromol. Biosci. 2009, 9:1154-1164.
32. Bourke S.L., Kohn J. Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv. Drug Deliv. Rev. 2003, 55:447-466.
33. Karp J.M., Langer R. Development and therapeutic applications of advanced biomaterials. Curr. Opin. Biotechnol. 2007, 18:454-459.
34. Langer R., Tirrell D.A. Designing materials for biology and medicine. Nature 2004, 428:487-492.
35. Hoffman A.S. The origins and evolution of "controlled" drug delivery systems. J. Control. Release 2008, 132:153-163.
36. Gong J., Chen M., Zheng Y., Wang S., Wang Y. Polymeric micelles drug delivery system in oncology. J. Control. Release 2012, 159:312-323.
37. Harada A., Kataoka K. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block-copolymers with poly(ethylene glycol) segments. Macromolecules 1995, 28:5294-5299.
38. Lavasanifar A., Samuel J., Sattari S., Kwon G.S. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm. Res. 2002, 19:418-422.
39. Falamarzian A., Lavasanifar A. Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B. Macromol. Biosci. 2010, 10:648-656.
40. Falamarzian A., Lavasanifar A. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B. Colloids Surf. B Biointerfaces 2010, 81:313-320.
41. Kim S.H., Tan J.P., Nederberg F., Fukushima K., Colson J., Yang C., Nelson A., Yang Y.Y., Hedrick J.L. Hydrogen bonding-enhanced micelle assemblies for drug delivery. Biomaterials 2010, 31:8063-8071.
42. Iijima M., Nagasaki Y., Okada T., Kato M., Kataoka K. Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers. Macromolecules 1999, 32:1140-1146.
43. Kim J.H., Emoto K., Iijima M., Nagasaki Y., Aoyagi T., Okano T., Sakurai Y., Kataoka K. Core-stabilized polymeric micelle as potential drug carrier: Increased solubilization of taxol. Polym. Adv. Technol. 1999, 10:647-654.
44. Kakizawa Y., Harada A., Kataoka K. Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J. Am. Chem. Soc. 1999, 121:11247-11248.
45. Nagarajan R., Barry M. Unusual Selectivity in Solubilization by Block Copolymer Micelles. Abstr Pap Am Chem S 1986, 191:287-COLL.
46. Shuai X., Ai H., Nasongkla N., Kim S., Gao J. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release 2004, 98:415-426.
47. Wang Y., Gao S., Ye W.H., Yoon H.S., Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat. Mater. 2006, 5:791-796.
48. Sun T.M., Du J.Z., Yao Y.D., Mao C.Q., Dou S., Huang S.Y., Zhang P.Z., Leong K.W., Song E.W., Wang J. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano 2011, 5:1483-1494.
49. Kaneshiro T.L., Lu Z.R. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 2009, 30:5660-5666.
50. Zhu C., Jung S., Luo S., Meng F., Zhu X., Park T.G., Zhong Z. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 2010, 31:2408-2416.
51. Xiong X.B., Lavasanifar A. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 2011, 5:5202-5213.
52. Fan L., Li F., Zhang H., Wang Y., Cheng C., Li X., Gu C.H., Yang Q., Wu H., Zhang S. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. Biomaterials 2010, 31:5634-5642.
53. Wiradharma N., Zhang Y., Venkataraman S., Hedrick J.L., Yang Y.Y. Self-assembled polymer nanostructures for delivery of anticancer therapeutics. Nano Today 2009, 4:302-317.
54. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 2006, 6:688-701.
55. Vicent M.J., Ringsdorf H., Duncan R. Polymer therapeutics: clinical applications and challenges for development Preface. Adv. Drug Deliv. Rev. 2009, 61:1117-1120.
56. Kopecek J., Bazilova H. Poly[N-(2-hydroxypropyl)methacrylamide].1. Radical polymerization and copolymerization. Eur. Polym. J. 1973, 9:7-14.
57. Vasey P.A., Kaye S.B., Morrison R., Twelves C., Wilson P., Duncan R., Thomson A.H., Murray L.S., Hilditch T.E., Murray T., Burtles S., Fraier D., Frigerio E., Cassidy J., C.R.C.P.I.I.Comm Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents - drug-polymer conjugates. Clin. Cancer Res. 1999, 5:83-94.
58. Li C., Yu D.F., Newman R.A., Cabral F., Stephens L.C., Hunter N., Milas L., Wallace S. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid) paclitaxel conjugate. Cancer Res. 1998, 58:2404-2409.
59. Singer J.W., Baker B., De Vries P., Kumar A., Shaffer S., Vawter E., Bolton M., Garzone P. Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX (TM)], a biodegradable polymeric drug conjugate - characterization, preclinical pharmacology, and preliminary clinical data. Polym. Drugs Clin. Stage Advant. Prospects 2003, 519:81-99.
60. Bhatt R., de Vries P., Tulinsky J., Bellamy G., Baker B., Singer J.W., Klein P. Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin. J. Med. Chem. 2003, 46:190-193.
61. Springett G.M., Takimoto C., McNamara M., Doroshow J.H., Syed S., Eastham E., Spriggs D., Pezzulli S., Michelson G., Dupont J. Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. J. Clin. Oncol. 2004, 22:3127.
62. Langer C.J., O'Byrne K.J., Socinski M.A., Mikhailov S.M., Lesniewski-Kmak K., Smakal M., Ciuleanu T.E., Orlov S.V., Dediu M., Heigener D., Eisenfeld A.J., Sandalic L., Oldham F.B., Singer J.W., Ross H.J. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer. J. Thorac. Oncol. 2008, 3:623-630.
63. Paz-Ares L., Ross H., O'Brien M., Riviere A., Gatzemeier U., Von Pawel J., Kaukel E., Freitag L., Digel W., Bischoff H., Garcia-Campelo R., Iannotti N., Reiterer P., Bover I., Prendiville J., Eisenfeld A.J., Oldham F.B., Bandstra B., Singer J.W., Bonomi P. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br. J. Cancer 2008, 98:1608-1613.
64. Canal F., Sanchis J., Vicent M.J. Polymer-drug conjugates as nano-sized medicines. Curr. Opin. Biotechnol. 2011, 22:894-900.
65. Tong R., Cheng J.J. Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles. Angew. Chem. Int. Ed. Engl. 2008, 47:4830-4834.
66. Tong R., Cheng J.J. Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. J. Am. Chem. Soc. 2009, 131:4744-4754.
67. Azzi J., Tang L., Moore R., Tong R., El Haddad N., Akiyoshi T., Mfarrej B., Yang S.M., Jurewicz M., Ichimura T., Lindeman N., Cheng J.J., Abdi R. Polylactide-cyclosporin A nanoparticles for targeted immunosuppression. FASEB J. 2010, 24:3927-3938.
68. Chen K.J., Tang L., Garcia M.A., Wang H., Lu H., Lin W.Y., Hou S., Yin Q., Shen C.K.F., Cheng J.J., Tseng H.R. The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles. Biomaterials 2012, 33:1162-1169.
69. Williams C.C., Thang S.H., Hantke T., Vogel U., Seeberger P.H., Tsanaktsidis J., Lepenies B. RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates. ChemMedChem 2012, 7:281-291.
70. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 2008, 60:1650-1662.
71. Felt O., Buri P., Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 1998, 24:979-993.
72. Friden P.M., Walus L.R., Musso G.F., Taylor M.A., Malfroy B., Starzyk R.M. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:4771-4775.
73. Li H., Qian Z.M. Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev. 2002, 22:225-250.
74. Qian Z.M., Li H., Sun H., Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 2002, 54:561-587.
75. Huang Y.F., Shangguan D., Liu H., Phillips J.A., Zhang X., Chen Y., Tan W. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBioChem 2009, 10:862-868.
76. Bagalkot V., Farokhzad O.C., Langer R., Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew. Chem. Int. Ed. 2006, 45:8149-8152.
77. Li T.H.L.H., Leong K.W. Nucleic acid-based nanoengineering: novel structures for biomedical applications. Interface Focus 2011, 1:702-724.
78. Ko S., Liu H., Chen Y., Mao C. DNA nanotubes as combinatorial vehicles for cellular delivery. Biomacromolecules 2008, 9:3039-3043.
79. Wilner O.I., Orbach R., Henning A., Teller C., Yehezkeli O., Mertig M., Harries D., Willner I. Self-assembly of DNA nanotubes with controllable diameters. Nat. Commun. 2011, 2:540.
80. Andersen E.S., Dong M., Nielsen M.M., Jahn K., Subramani R., Mamdouh W., Golas M.M., Sander B., Stark H., Oliveira C.L., Pedersen J.S., Birkedal V., Besenbacher F., Gothelf K.V., Kjems J. Self-assembly of a nanoscale DNA box with a controllable lid. Nature 2009, 459:73-76.
81. Roh Y.H., Lee J.B., Kiatwuthinon P., Hartman M.R., Cha J.J., Um S.H., Muller D.A., Luo D. DNAsomes: multifunctional DNA-based nanocarriers. Small 2011, 7:74-78.
82. Li J., Pei H., Zhu B., Liang L., Wei M., He Y., Chen N., Li D., Huang Q., Fan C. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano 2011, 5:8783-8789.
83. Afonin K.A., Grabow W.W., Walker F.M., Bindewald E., Dobrovolskaia M.A., Shapiro B.A., Jaeger L. Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat. Protoc. 2011, 6:2022-2034.
84. Alahari S.K., Dean N.M., Fisher M.H., Delong R., Manoharan M., Tivel K.L., Juliano R.L. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 1996, 50:808-819.
85. Jeong J.H., Mok H., Oh Y.K., Park T.G. siRNA conjugate delivery systems. Bioconjug. Chem. 2009, 20:5-14.
86. Cronican J.J., Thompson D.B., Beier K.T., McNaughton B.R., Cepko C.L., Liu D.R. Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem. Biol. 2010, 5:747-752.
87. McNaughton B.R., Cronican J.J., Thompson D.B., Liu D.R. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6111-6116.
88. Frandsen J.L., Ghandehari H. Recombinant protein-based polymers for advanced drug delivery. Chem. Soc. Rev. 2012, 41:2696-2706.
89. MacKay J.A., Chen M., McDaniel J.R., Liu W., Simnick A.J., Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat. Mater. 2009, 8:993-999.
90. Meyer D.E., Shin B.C., Kong G.A., Dewhirst M.W., Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J. Control. Release 2001, 74:213-224.
91. Dreher M.R., Liu W., Michelich C.R., Dewhirst M.W., Chilkoti A. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res. 2007, 67:4418-4424.
92. Dreher M.R., Simnick A.J., Fischer K., Smith R.J., Patel A., Schmidt M., Chilkoti A. Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J. Am. Chem. Soc. 2008, 130:687-694.
93. Sallach R.E., Cui W., Wen J., Martinez A., Conticello V.P., Chaikof E.L. Elastin-mimetic protein polymers capable of physical and chemical crosslinking. Biomaterials 2009, 30:409-422.
94. Kim W., Chaikof E.L. Recombinant elastin-mimetic biomaterials: emerging applications in medicine. Adv. Drug Deliv. Rev. 2010, 62:1468-1478.
95. Jordan S.W., Haller C.A., Sallach R.E., Apkarian R.P., Hanson S.R., Chaikof E.L. The effect of a recombinant elastin-mimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt. Biomaterials 2007, 28:1191-1197.
96. Wu X., Sallach R.E., Caves J.M., Conticello V.P., Chaikof E.L. Deformation responses of a physically cross-linked high molecular weight elastin-like protein polymer. Biomacromolecules 2008, 9:1787-1794.
97. Numata K., Subramanian B., Currie H.A., Kaplan D.L. Bioengineered silk protein-based gene delivery systems. Biomaterials 2009, 30:5775-5784.
98. Numata K., Kaplan D.L. Silk-based delivery systems of bioactive molecules. Adv. Drug Deliv. Rev. 2010, 62:1497-1508.
99. Numata K., Kaplan D.L. Silk-based gene carriers with cell membrane destabilizing peptides. Biomacromolecules 2010, 11:3189-3195.
100. Kim S., Kim J.H., Jeon O., Kwon I.C., Park K. Engineered polymers for advanced drug delivery. Eur. J. Pharm. Biopharm. 2009, 71:420-430.
101. He J., Qi X., Miao Y., Wu H.L., He N., Zhu J.J. Application of smart nanostructures in medicine. Nanomedicine (Lond.) 2010, 5:1129-1138.
102. Tarahovsky Y.S. "Smart" liposomal nanocontainers in biology and medicine. Biochemistry (Mosc) 2010, 75:811-824.
103. MacEwan S.R., Callahan D.J., Chilkoti A. Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond.) 2010, 5:793-806.
104. Schmaljohann D. Thermo- and pH-responsive polymers in drug delivery. Adv. Drug Deliv. Rev. 2006, 58:1655-1670.
105. Brocchini S., James K., Tangpasuthadol V., Kohn J. A combinatorial approach for polymer design. J. Am. Chem. Soc. 1997, 119:4553-4554.
106. Mora-Huertas C.E., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010, 385:113-142.
107. Love K.T., Mahon K.P., Levins C.G., Whitehead K.A., Querbes W., Dorkin J.R., Qin J., Cantley W., Qin L.L., Racie T., Frank-Kamenetsky M., Yip K.N., Alvarez R., Sah D.W., de Fougerolles A., Fitzgerald K., Koteliansky V., Akinc A., Langer R., Anderson D.G. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:1864-1869.
108. Weissleder R., Kelly K., Sun E.Y., Shtatland T., Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol. 2005, 23:1418-1423.
109. Vauthier C., Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 2009, 26:1025-1058.
110. Ganachaud F., Katz J.L. Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. ChemPhysChem 2005, 6:209-216.
111. Duclairoir C., Nakache E., Marchais H., Orecchioni A.M. Formation of gliadin nanoparticles: influence of the solubility parameter of the protein solvent. Colloid Polym. Sci. 1998, 276:321-327.
112. Skiba M., Wouessidjewe D., Puisieux F., Duchene D., Gulik A. Characterization of amphiphilic beta-cyclodextrin nanospheres. Int. J. Pharm. 1996, 142:121-124.
113. McGinity J.W., O'Donnell P.B. Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev. 1997, 28:25-42.
114. Desgouilles S., Vauthier C., Bazile D., Vacus J., Grossiord J.-L., Veillard M., Couvreur P. The design of nanoparticles obtained by solvent evaporation: a comprehensive study. Langmuir 2003, 19:9504-9510.
115. Lemoine D., Preat V. Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J. Control. Release 1998, 54:15-27.
116. Yang Y.Y., Chung T.S., Ng N.P. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001, 22:231-241.
117. Bilati U., Allemann E., Doelker E. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm. Dev. Technol. 2003, 8:1-9.
118. Leroux J.C., Allemann E., Doelker E., Gurny R. New approach for the preparation of nanoparticles by an emulsification-diffusion method. Eur. J. Pharm. Biopharm. 1995, 41:14-18.
119. Moinard-Checot D., Chevalier Y., Briancon S., Fessi H., Guinebretiere S. Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process. J. Nanosci. Nanotechnol. 2006, 6:2664-2681.
120. Allémann E., Gurny R., Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size. Int. J. Pharm. 1992, 87:247-253.
121. Zhang Z., Grijpma D.W., Feijen J. Poly(trimethylene carbonate) and monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) nanoparticles for the controlled release of dexamethasone. J. Control. Release 2006, 111:263-270.
122. Krol S., Diaspro A., Cavalleri O., Cavanna D., Ballario P., Grimaldi B., Filetici P., Ornaghi P., Gliozzi A. Nanocapsule - A Novel Tool for Medicine and Science. Frontiers of multifunctional integrated nanosytems 2004, 439-446. Academic Publishers, the Netherlands. E. Buzaneva, P. Scharff (Eds.).
123. Agarwal A., Lvov Y., Sawant R., Torchilin V. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. J. Control. Release 2008, 128:255-260.
124. Dai Z., Heilig A., Zastrow H., Donath E., Mohwald H. Novel formulations of vitamins and insulin by nanoengineering of polyelectrolyte multilayers around microcrystals. Chemistry 2004, 10:6369-6374.
125. Palankar R., Skirtach A.G., Kreft O., Bedard M., Garstka M., Gould K., Mohwald H., Sukhorukov G.B., Winterhalter M., Springer S. Controlled intracellular release of peptides from microcapsules enhances antigen presentation on MHC class I molecules. Small 2009, 5:2168-2176.
126. Aouadi M., Tesz G.J., Nicoloro S.M., Wang M., Chouinard M., Soto E., Ostroff G.R., Czech M.P. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 2009, 458:1180-1184.
127. DeMello A.J. Control and detection of chemical reactions in microfluidic systems. Nature 2006, 442:394-402.
128. Duncanson W.J., Lin T., Abate A.R., Seiffert S., Shah R.K., Weitz D.A. Microfluidic synthesis of advanced microparticles for encapsulation and controlled release. Lab Chip 2012, 12:2135-2145.
129. Lensen D., van Breukelen K., Vriezema D.M., van Hest J.C. Preparation of biodegradable liquid core PLLA microcapsules and hollow PLLA microcapsules using microfluidics. Macromol. Biosci. 2010, 10:475-480.
130. Okochi H., Nakano M. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv. Drug Deliv. Rev. 2000, 45:5-26.
131. Utada A.S., Lorenceau E., Link D.R., Kaplan P.D., Stone H.A., Weitz D.A. Monodisperse double emulsions generated from a microcapillary device. Science 2005, 308:537-541.
132. Endres T., Zheng M., Beck-Broichsitter M., Samsonova O., Debus H., Kissel T. Optimising the self-assembly of siRNA loaded PEG-PCL-lPEI nano-carriers employing different preparation techniques. J. Control. Release 2012, 160:583-591.
133. Kim J.W., Utada A.S., Fernandez-Nieves A., Hu Z., Weitz D.A. Fabrication of monodisperse gel shells and functional microgels in microfluidic devices. Angew. Chem. Int. Ed. Engl. 2007, 46:1819-1822.
134. Shah R.K., J.W.K., Agresti J.J., Weitz D.A., Chu L.Y. Fabrication of monodisperse thermosensitive microgels and gel capsules in microfluidic devices. Soft Matter 2008, 4:2303-2309.
135. Breslauer D.N., Muller S.J., Lee L.P. Generation of monodisperse silk microspheres prepared with microfluidics. Biomacromolecules 2010, 11:643-647.
136. Chu L.Y., J.Y.K., Shah R.K., Weitz D.A. Monodisperse thermoresponsive microgels with tunable volume-phase transition kinetics. Adv. Funct. Mater. 2007, 17:3499-3504.
137. Wang W., Xie R., Ju X.J., Luo T., Liu L., Weitz D.A., Chu L.Y. Controllable microfluidic production of multicomponent multiple emulsions. Lab Chip 2011, 11:1587-1592.
138. Chu L.Y., Utada A.S., Shah R.K., Kim J.W., Weitz D.A. Controllable monodisperse multiple emulsions. Angew. Chem. Int. Ed. Engl. 2007, 46:8970-8974.
139. Kim S.H., Kim J.W., Cho J.C., Weitz D.A. Double-emulsion drops with ultra-thin shells for capsule templates. Lab Chip 2011, 11:3162-3166.
140. Ren P.W., Ju X.J., Xie R., Chu L.Y. Monodisperse alginate microcapsules with oil core generated from a microfluidic device. J. Colloid Interface Sci. 2010, 343:392-395.
141. Shah R.K., Kim J.W., Weitz D.A. Monodisperse stimuli-responsive colloidosomes by self-assembly of microgels in droplets. Langmuir 2010, 26:1561-1565.
142. Liu L., Yang J.P., Ju X.J., Xie R., Liu Y.M., Wang W., Zhang J.J., Niu C.H., Chu L.Y. Monodisperse core-shell chitosan microcapsules for pH-responsive burst release of hydrophobic drugs. Soft Matter 2011, 7:4821-4827.
143. Romanowsky M.B., Abate A.R., Rotem A., Holtze C., Weitz D.A. High throughput production of single core double emulsions in a parallelized microfluidic device. Lab Chip 2012, 12:802-807.
144. Hsieh A.T., Hori N., Massoudi R., Pan P.J., Sasaki H., Lin Y.A., Lee A.P. Nonviral gene vector formation in monodispersed picolitre incubator for consistent gene delivery. Lab Chip 2009, 9:2638-2643.
145. Ho Y.P., Grigsby C.L., Zhao F., Leong K.W. Tuning physical properties of nanocomplexes through microfluidics-assisted confinement. Nano Lett. 2011, 11:2178-2182.
146. Karnik R., Gu F., Basto P., Cannizzaro C., Dean L., Kyei-Manu W., Langer R., Farokhzad O.C. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008, 8:2906-2912.
147. Kolishetti N., Dhar S., Valencia P.M., Lin L.Q., Karnik R., Lippard S.J., Langer R., Farokhzad O.C. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:17939-17944.
148. Valencia P.M., Basto P.A., Zhang L., Rhee M., Langer R., Farokhzad O.C., Karnik R. Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano 2010, 4:1671-1679.
149. Gong X., Peng S., Wen W., Sheng P., Li W. Design and Fabrication of Magnetically Functionalized Core/Shell Microspheres for Smart Drug Delivery. Adv. Funct. Mater. 2008, 18:1-6.
150. He T., Q.L., Zhang K., Mu X., Luo T., Wang Y., Luo G. A modified microfluidic chip for fabrication of paclitaxel-loaded poly(L-lactic acid) microspheres. Microfluid. Nanofluid. 2011, 10:1289-1298.
151. Watanabe T., T.O., Kimura Y. Continuous fabrication of monodisperse polylactide microspheres by droplet - particle technology using microfluidic emulsification and emulsion-solvent diffusion. Soft Matter 2011, 7:9894-9897.
152. Seiffert S., D.A.W. Controlled fabrication of polymer microgels by polymer-analogous gelation in droplet microfluidics. Soft Matter 2010, 6:3184-3190.
153. Chen W., Yang Y., Rinadi C., Zhou D., Shen A.Q. Formation of supramolecular hydrogel microspheres via microfluidics. Lab Chip 2009, 9:2947-2951.
154. Lee I., Y.Y., Cheng Z., Jeong H.K. Generation of monodisperse mesoporous silica microspheres with controllable size and surface morphology in a microfluidic device. Adv. Funct. Mater. 2008, 18:4014-4021.
155. Huang S., Lin B., Qin J. Microfluidic synthesis of tunable poly-(N-isopropylacrylamide) microparticles via PEG adjustment. Electrophoresis 2011, 32:3364-3370.
156. Hung L.H., Teh S.Y., Jester J., Lee A.P. PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches. Lab Chip 2010, 10:1820-1825.
157. Xu Q., Hashimoto M., Dang T.T., Hoare T., Kohane D.S., Whitesides G.M., Langer R., Anderson D.G. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 2009, 5:1575-1581.
158. Kesselman L.R., Shinwary S., Selvaganapathy P.R., Hoare T. Synthesis of monodisperse, covalently cross-linked, degradable "smart" microgels using microfluidics. Small 2012, 8:1092-1098.
159. Marimuthu M., S.K., An J. Amphiphilic triblock copolymer and a microfluidic device for porous microfiber fabrication. Soft Matter 2010, 6:2200-2207.
160. Hettiarachchi K., Zhang S., Feingold S., Lee A.P., Dayton P.A. Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy. Biotechnol. Prog. 2009, 25:938-945.
161. Jagadeesan D., Nasimova I., Gourevich I., Starodubtsev S., Kumacheva E. Microgels for the encapsulation and stimulus-responsive release of molecules with distinct polarities. Macromol. Biosci. 2011, 11:889-896.
162. Shin S.J., Park J.Y., Lee J.Y., Park H., Park Y.D., Lee K.B., Whang C.M., Lee S.H. "On the fly" continuous generation of alginate fibers using a microfluidic device. Langmuir 2007, 23:9104-9108.
163. Su J., Zheng Y., Wu H. Generation of alginate microfibers with a roller-assisted microfluidic system. Lab Chip 2009, 9:996-1001.
164. Choi C.H., Yi H., Hwang S., Weitz D.A., Lee C.S. Microfluidic fabrication of complex-shaped microfibers by liquid template-aided multiphase microflow. Lab Chip 2011, 11:1477-1483.
165. Dendukuri D., Pregibon D.C., Collins J., Hatton T.A., Doyle P.S. Continuous-flow lithography for high-throughput microparticle synthesis. Nat. Mater. 2006, 5:365-369.
166. De Geest B.G., Urbanski J.P., Thorsen T., Demeester J., De Smedt S.C. Synthesis of monodisperse biodegradable microgels in microfluidic devices. Langmuir 2005, 21:10275-10279.
167. Choi C.H., Jung J.H., Kim D.W., Chung Y.M., Lee C.S. Novel one-pot route to monodisperse thermosensitive hollow microcapsules in a microfluidic system. Lab Chip 2008, 8:1544-1551.
168. Jahn A., Vreeland W.N., Gaitan M., Locascio L.E. Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. J. Am. Chem. Soc. 2004, 126:2674-2675.
169. Jahn A., Vreeland W.N., DeVoe D.L., Locascio L.E., Gaitan M. Microfluidic directed formation of liposomes of controlled size. Langmuir 2007, 23:6289-6293.
170. Jahn A., Stavis S.M., Hong J.S., Vreeland W.N., DeVoe D.L., Gaitan M. Microfluidic mixing and the formation of nanoscale lipid vesicles. ACS Nano 2010, 4:2077-2087.
171. Tran T.H., Nguyen C.T., Kim D.P., Lee Y.K., Huh K.M. Microfluidic approach for highly efficient synthesis of heparin-based bioconjugates for drug delivery. Lab Chip 2012, 12:589-594.
172. Xu J.H., H.Z., Lan W.J., Luo G.S. A novel microfluidic approach for monodispersed chitosan microspheres with controllable structures. Adv. Healthc. Mater. 2012, 1:106-111.
173. Xu J.H., Li S.W., Tostado C., Lan W.J., Luo G.S. Preparation of monodispersed chitosan microspheres and in situ encapsulation of BSA in a co-axial microfluidic device. Biomed. Microdevices 2009, 11:243-249.
174. Nie Z., Li W., Seo M., Xu S., Kumacheva E. Janus and ternary particles generated by microfluidic synthesis: design, synthesis, and self-assembly. J. Am. Chem. Soc. 2006, 128:9408-9412.
175. Ogonczyk D., Siek M., Garstecki P. Microfluidic formulation of pectin microbeads for encapsulation and controlled release of nanoparticles. Biomicrofluidics 2011, 5:13405.
176. Xie H., She Z.G., Wang S., Sharma G., Smith J.W. One-step fabrication of polymeric Janus nanoparticles for drug delivery. Langmuir 2012, 28:4459-4463.
177. Hong J.S., Stavis S.M., DePaoli Lacerda S.H., Locascio L.E., Raghavan S.R., Gaitan M. Microfluidic directed self-assembly of liposome-hydrogel hybrid nanoparticles. Langmuir 2010, 26:11581-11588.
178. Engel R.H., Riggi S.J., Fahrenbach M.J. Insulin: intestinal absorption as water-in-oil-in-water emulsions. Nature 1968, 219:856-857.
179. Muguet V., Seiller M., Barratt G., Ozer O., Marty J.P., Grossiord J.L. Formulation of shear rate sensitive multiple emulsions. J. Control. Release 2001, 70:37-49.
180. Gokmen M.T., De Geest B.G., Hennink W.E., Du Prez F.E. "Giant" hollow multilayer capsules by microfluidic templating. ACS Appl. Mater. Interfaces 2009, 1:1196-1202.
181. Seiffert S., Thiele J., Abate A.R., Weitz D.A. Smart microgel capsules from macromolecular precursors. J. Am. Chem. Soc. 2010, 132:6606-6609.
182. Lavin D.M., Stefani R.M., Zhang L., Furtado S., Hopkins R.A., Mathiowitz E. Multifunctional polymeric microfibers with prolonged drug delivery and structural support capabilities. Acta Biomater. 2012, 8:1891-1900.
183. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., DeSimone J.M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11613-11618.
184. Champion J.A., Katare Y.K., Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release 2007, 121:3-9.
185. Nisisako T., Torii T. Microfluidic large-scale integration on a chip for mass production of monodisperse droplets and particles. Lab Chip 2008, 8:287-293.
186. Kobayashi I., Y.W., Uemura K., Nakajima M. Microchannel emulsification for mass production of uniform fine droplets: integration of microchannel arrays on a chip. Microfluid. Nanofluid. 2010, 8:255-262.
187. Guzowski J., Korczyk P.M., Jakiela S., Garstecki P. Automated high-throughput generation of droplets. Lab Chip 2011, 11:3593-3595.
188. MacDonald M.P., Spalding G.C., Dholakia K. Microfluidic sorting in an optical lattice. Nature 2003, 426:421-424.
189. Huh D., Bahng J.H., Ling Y., Wei H.H., Kripfgans O.D., Fowlkes J.B., Grotberg J.B., Takayama S. Gravity-driven microfluidic particle sorting device with hydrodynamic separation amplification. Anal. Chem. 2007, 79:1369-1376.
190. Yamada M., Seki M. Hydrodynamic filtration for on-chip particle concentration and classification utilizing microfluidics. Lab Chip 2005, 5:1233-1239.
191. Huang L.R., Cox E.C., Austin R.H., Sturm J.C. Continuous particle separation through deterministic lateral displacement. Science 2004, 304:987-990.
192. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., Discher D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2:249-255.
193. Merkel T.J., Herlihy K.P., Nunes J., Orgel R.M., Rolland J.P., DeSimone J.M. Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles. Langmuir 2010, 26:13086-13096.
194. Ho C.C., Keller A., Odell J.A., Ottewill R.H. Preparation of monodisperse ellipsoidal polystyrene particles. Colloid Polym. Sci. 1993, 271:469-479.
195. Champion J.A., Katare Y.K., Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11901-11904.
196. Rolland J.P., Maynor B.W., Euliss L.E., Exner A.E., Denison G.M., DeSimone J.M. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 2005, 127:10096-10100.
197. Petros R.A., Ropp P.A., DeSimone J.M. Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells. J. Am. Chem. Soc. 2008, 130:5008-5009.
198. Parrott M.C., Luft J.C., Byrne J.D., Fain J.H., Napier M.E., Desimone J.M. Tunable bifunctional silyl ether cross-linkers for the design of acid-sensitive biomaterials. J. Am. Chem. Soc. 2010, 132:17928-17932.
199. Euliss L.E., DuPont J.A., Gratton S., DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 2006, 35:1095-1104.
200. Nunes J., Herlihy K.P., Mair L., Superfine R., DeSimone J.M. Multifunctional shape and size specific magneto-polymer composite particles. Nano Lett. 2010, 10:1113-1119.
201. Canelas D.A., Herlihy K.P., DeSimone J.M. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1:391-404.
202. Glangchai L.C., Caldorera-Moore M., Shi L., Roy K. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J. Control. Release 2008, 125:263-272.
203. Mogul R., Bol'shakov A.A., Chan S.L., Stevens R.M., Khare B.N., Meyyappan M., Trent J.D. Impact of low-temperature plasmas on deinococcusradiodurans and biomolecules. Biotechnol. Prog. 2003, 19:776-783.
204. Panda P., Ali S., Lo E., Chung B.G., Hatton T.A., Khademhosseini A., Doyle P.S. Stop-flow lithography to generate cell-laden microgel particles. Lab Chip 2008, 8:1056-1061.
205. Dendukuri D., Gu S.S., Pregibon D.C., Hatton T.A., Doyle P.S. Stop-flow lithography in a microfluidic device. Lab Chip 2007, 7:818-828.